Shotlee LogoShotlee
Blog
Download on theApp Store
Get it onGoogle Play
Skip to main content
AI: Music's Ozempic? Suno Co-Founder Says It's Happening Quietly - Featured image
AI & Music Technology

AI: Music's Ozempic? Suno Co-Founder Says It's Happening Quietly

Dr. Adrian Vale, MD
Reviewed by Dr. Adrian Vale, MDInternal Medicine · Board-Certified Obesity Medicine
·March 30, 2026·5 min read

On this page

  • The Ozempic Analogy: Why It Resonates in Music Production
  • Suno's Vision: Pushing Music Forward
  • Training Data: Open Internet, Copyright, and Trade Secrets
  • Debunking 'AI Slop': A Personal Perspective
  • The 10,000-Hour Rule: AI Doesn't Shortchange Mastery
  • Key Takeaways: What This Means for Musicians and Fans
  • Practical Guidance for Musicians Exploring AI Tools

Track Smart

Calculate active GLP-1 levels automatically with Shotlee.

Download →

In a candid Guardian interview, Suno co-founder Mikey Shulman likens AI in music production to Ozempic in weight loss—ubiquitous yet unspoken. He argues AI tools like Suno's empower new creators, invent genres, and streamline tedious production tasks. Despite copyright debates, Shulman insists mastery still demands 10,000 hours.

Share

On this page

  • The Ozempic Analogy: Why It Resonates in Music Production
  • Suno's Vision: Pushing Music Forward
  • Training Data: Open Internet, Copyright, and Trade Secrets
  • Debunking 'AI Slop': A Personal Perspective
  • The 10,000-Hour Rule: AI Doesn't Shortchange Mastery
  • Key Takeaways: What This Means for Musicians and Fans
  • Practical Guidance for Musicians Exploring AI Tools

AI: Music's Ozempic? Suno Co-Founder Says It's Happening Quietly

The debate over AI in music production mirrors broader tensions in creative industries: Is it a threat to artistry or a democratizing force? Opinions range from fears of diminished human creativity to views of AI as an essential production aid. Enter Mikey Shulman, co-founder of AI music company Suno, who in a recent The Guardian interview draws a provocative parallel: AI's role in modern music is akin to Ozempic in weight loss. "Everybody is on it and nobody wants to talk about it," he asserts.

This analogy captures the covert adoption of AI tools amid public skepticism. Ozempic, a GLP-1 receptor agonist primarily for type 2 diabetes, gained fame for its weight loss effects, transforming personal health routines quietly among users. Similarly, Shulman positions Suno's software as an invisible accelerator in music creation, enabling faster experimentation without fanfare.

The Ozempic Analogy: Why It Resonates in Music Production

Shulman's comparison highlights a cultural phenomenon: tools that deliver results but carry stigma. Just as Ozempic users might downplay its role in their transformation due to side effect discussions or perceptions of 'easy' weight loss, musicians hesitate to admit AI assistance. "It was described to me that we're the Ozempic of the music industry," Shulman notes. "Everybody is on it, and nobody wants to talk about it."

This secrecy stems from production realities. Traditional music-making involves hours of repetitive tasks—layering tracks, mixing, and refining sounds—that many find draining. Shulman reveals: "I think the majority of people don't enjoy the majority of the time they spend making music." In private conversations, creators confess relief from AI's efficiency, allowing focus on inspiration over drudgery.

For newcomers, AI lowers barriers. Shulman envisions it fostering discovery: "new people get discovered" and "new genres get invented." This aligns with AI's generative capabilities, where users input prompts to produce full tracks, blending human intent with machine execution.

Suno's Vision: Pushing Music Forward

Shulman describes Suno's software as a catalyst for evolution. "He sees software like that created by his company as something that 'pushes music forward,'" per the interview. By handling mundane elements, AI frees artists to explore unconventional ideas, potentially birthing hybrid styles unimaginable in analog eras.

Consider the workflow shift: Bedroom producers, once limited by gear costs and technical skills, now generate professional demos instantly. This mirrors how tools like Auto-Tune revolutionized vocals—initially controversial, now standard. Suno positions itself not as a replacement but an enhancer, amplifying human creativity.

Practical Guidance for Musicians Exploring AI Tools

  • Start Simple: Use AI for ideation—generate beats or lyrics from text prompts.
  • Integrate Thoughtfully: Layer AI outputs with personal recordings for authenticity.
  • Discuss Ethically: Be transparent in collaborations; audiences value knowing when AI contributes.
  • Experiment with Genres: Test prompts for fusions like 'cyber-folk trap' to invent sounds.

Shulman emphasizes AI's role in accessibility, especially for non-traditional musicians lacking formal training.

Precision tracking for your journey

Join thousands using Shotlee to accurately track GLP-1 medications and side effects.

📱 Get the Shotlee App

Track your GLP-1 medications, peptides, and health metrics on the go with our mobile app!

Download on theApp Store
Get it onGoogle Play

Training Data: Open Internet, Copyright, and Trade Secrets

Suno's models are "trained on medium- and high-quality music we can find on the open internet," Shulman explains. When pressed on copyrighted material, he demurs: "Copyright is a different thing. I can't get into too many specifics because there is active legal stuff going on, and also some of it is trade secrets."

This touches core AI ethics in music. Public datasets abound, but lawsuits from labels question fair use. Competitors like Udio face similar scrutiny, underscoring industry growing pains. For users, this means monitoring legal updates—tools may evolve with licensed data to mitigate risks.

Background on AI training: Models learn patterns from vast audio libraries, predicting notes, rhythms, and timbres. 'Open internet' likely includes Creative Commons tracks, user uploads, and public domain works, though boundaries blur.

Debunking 'AI Slop': A Personal Perspective

Critics decry 'AI slop'—low-effort, generic outputs flooding platforms. Shulman counters subjectively: "I made a really funny song with my four-year-old yesterday morning. That is 'slop' to you - you don't care about it - but I love it. It's fantastic."

This reframes value: Output quality is contextual. Professional releases demand polish, but AI excels in playful prototyping. It democratizes joy in creation, much like garage bands jamming imperfectly. For pros, AI slop serves as raw material, refined through human curation.

The 10,000-Hour Rule: AI Doesn't Shortchange Mastery

Referencing Malcolm Gladwell's Outliers—where 10,000 hours define expertise—Shulman affirms its relevance. "I think people will (still) have to spend 10,000 hours," he states. "They may be doing different things and practising different skills, but they will certainly need to spend 10,000 hours to make the best music in the world."

AI shifts hours from technical grind to artistic depth: prompt engineering, sound design critique, audience engagement. Top artists will master AI-human symbiosis, not abandon effort. Comparisons to chess engines show computers aid grandmasters without replacing study.

Key Takeaways: What This Means for Musicians and Fans

  • AI adoption in music is widespread but understated, like Ozempic's cultural footprint.
  • Suno empowers efficiency, discovery, and innovation without negating hard work.
  • Copyright challenges persist, but transparent practices build trust.
  • Personal value trumps perfection—AI fosters fun alongside professionalism.
  • Mastery endures: 10,000 hours evolve, focusing on high-level skills.

In conclusion, Shulman's interview spotlights AI's transformative yet hushed presence in music. As tools like Suno mature, expect bolder integration, new voices, and ethical frameworks. Musicians: Experiment privately, credit publicly, and invest those hours wisely. The future of music? Augmented, not automated.

?Frequently Asked Questions

What did Mikey Shulman compare AI in music to?

Mikey Shulman, Suno co-founder, compared AI music tools to Ozempic in weight loss, saying 'Everybody is on it and nobody wants to talk about it' due to widespread but unspoken adoption.

How does Suno train its AI music models?

Suno trains on medium- and high-quality music from the open internet, though specifics on copyrighted material are limited due to ongoing legal issues and trade secrets.

Does AI eliminate the need for 10,000 hours in music mastery?

No, Shulman affirms artists still need 10,000 hours, but they'll practice different skills like prompt engineering and curation in an AI-assisted workflow.

What is 'AI slop' according to Suno's co-founder?

Shulman views 'AI slop' subjectively, citing a funny song made with his four-year-old as an example that's dismissible to outsiders but personally fantastic.

How does AI like Suno benefit new musicians?

It streamlines tedious production tasks, helps new people get discovered, and enables invention of new genres by pushing music forward.

Source Information

Originally published by VICE.Read the original article →

Read next

Keep exploring

More on Ozempic

Articles covering Ozempic dosing, side effects, and clinical updates.

Alli Weight Loss Pill: FDA Flags Serious Kidney Risks
Health & Wellness

Alli Weight Loss Pill: FDA Flags Serious Kidney Risks

The Food and Drug Administration (FDA) has issued a new warning regarding potential serious kidney complications associated with Alli, the sole over-the-counter weight loss medication available in the United States. The drug's label has been updated to reflect these risks, urging caution for consumers.

8 min read
Beyond Weight Loss: How GLP-1s Impact Your Blood Pressure
Health & Wellness

Beyond Weight Loss: How GLP-1s Impact Your Blood Pressure

GLP-1 receptor agonists, known for their role in diabetes and weight management, are increasingly recognized for their broader health benefits, including effects on blood pressure. This article delves into how these medications work, their impact on cardiovascular health, and whether they are safe for individuals with hypertension.

8 min read
Wegovy Pill Arrives in the UK: A New Era for Weight Management?
Health & Wellness

Wegovy Pill Arrives in the UK: A New Era for Weight Management?

The UK has officially approved a pill version of the popular Wegovy weight-loss drug, marking a significant advancement in accessible obesity treatment. This development offers a convenient alternative to weekly injections for many.

6 min read
Share this article
  1. Home
  2. Blog
  3. AI: Music's Ozempic? Suno Co-Founder Says It's Happening Quietly
Dr. Adrian Vale, MD — Internal Medicine · Board-Certified Obesity Medicine
Medically reviewed

Dr. Adrian Vale, MD

Internal Medicine · Board-Certified Obesity Medicine

Dr. Adrian Vale is a board-certified internal medicine physician with a clinical focus on obesity medicine and metabolic health. He reviews Shotlee guides and articles on GLP-1 medications, peptide therapy, and weight-management protocols for clinical accuracy.

View all articles reviewed by Dr. Adrian Vale, MD
Shotlee LogoShotlee

Your comprehensive health tracking companion. Track, analyze, and optimize your journey with advanced metrics and community support.

Product

  • Medication Trackers
  • Health Guides
  • Calculators
  • Compare Medications
  • Pricing

Resources

  • Health Blog
  • Support Center

Legal

  • Privacy Policy
  • Terms of Service
  • Community Guidelines
  • Refund Policy

© 2026 Shotlee. All rights reserved.

Made with for the community♥ for the community